Samjin Pharmaceuticals Co., Ltd. 005500.KS Stock
Samjin Pharmaceuticals Co., Ltd. Price Chart
Samjin Pharmaceuticals Co., Ltd. 005500.KS Financial and Trading Overview
Samjin Pharmaceuticals Co., Ltd. stock price | 19860 KRW |
Previous Close | 20950 KRW |
Open | 21150 KRW |
Bid | 21350 KRW x 0 |
Ask | 21450 KRW x 0 |
Day's Range | 20950 - 21500 KRW |
52 Week Range | 19990 - 28500 KRW |
Volume | 36.55K KRW |
Avg. Volume | 48.63K KRW |
Market Cap | 278.24B KRW |
Beta (5Y Monthly) | 0.446575 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 800 (3.76%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | 34000 KRW |
005500.KS Valuation Measures
Enterprise Value | 310.43B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.0153747 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.133 |
Enterprise Value/EBITDA | 9.407 |
Trading Information
Samjin Pharmaceuticals Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.446575 |
52-Week Change | -14.48% |
S&P500 52-Week Change | 20.43% |
52 Week High | 28500 KRW |
52 Week Low | 19990 KRW |
50-Day Moving Average | 22472 KRW |
200-Day Moving Average | 24128.75 KRW |
005500.KS Share Statistics
Avg. Volume (3 month) | 48.63K KRW |
Avg. Daily Volume (10-Days) | 44.59K KRW |
Shares Outstanding | 13M |
Float | 5.53M |
Short Ratio | N/A |
% Held by Insiders | 46.20% |
% Held by Institutions | 3.16% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 290.00% |
Payout Ratio | 0.463 |
Last Split Factor | 1.03121:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2013 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.98% |
Operating Margin (ttm) | 8.45% |
Gross Margin | 42.96% |
EBITDA Margin | 12.04% |
Management Effectiveness
Return on Assets (ttm) | 3.92% |
Return on Equity (ttm) | 8.58% |
Income Statement
Revenue (ttm) | 274.03B KRW |
Revenue Per Share (ttm) | 21626.05 KRW |
Quarterly Revenue Growth (yoy) | -1.50% |
Gross Profit (ttm) | N/A |
EBITDA | 33B KRW |
Net Income Avi to Common (ttm) | 21.89B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 59.09% |
Balance Sheet
Total Cash (mrq) | 6.53B KRW |
Total Cash Per Share (mrq) | 515.52 KRW |
Total Debt (mrq) | 51.5B KRW |
Total Debt/Equity (mrq) | 46.73 KRW |
Current Ratio (mrq) | 1.644 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 17.29B KRW |
Levered Free Cash Flow (ttm) | -11924214784 KRW |
Profile of Samjin Pharmaceuticals Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 121 Wausan Ro |
ZIP | 04054 |
Phone | 82 2 3140 0700 |
Website | https://www.samjinpharm.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 586 |
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.
Q&A For Samjin Pharmaceuticals Co., Ltd. Stock
What is a current 005500.KS stock price?
Samjin Pharmaceuticals Co., Ltd. 005500.KS stock price today per share is 19860 KRW.
How to purchase Samjin Pharmaceuticals Co., Ltd. stock?
You can buy 005500.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Samjin Pharmaceuticals Co., Ltd.?
The stock symbol or ticker of Samjin Pharmaceuticals Co., Ltd. is 005500.KS.
Which industry does the Samjin Pharmaceuticals Co., Ltd. company belong to?
The Samjin Pharmaceuticals Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Samjin Pharmaceuticals Co., Ltd. have in circulation?
The max supply of Samjin Pharmaceuticals Co., Ltd. shares is 12.77M.
What is Samjin Pharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Samjin Pharmaceuticals Co., Ltd. PE Ratio is now.
What was Samjin Pharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Samjin Pharmaceuticals Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Samjin Pharmaceuticals Co., Ltd. company belong to?
The Samjin Pharmaceuticals Co., Ltd. sector is Healthcare.